Cargando…
CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
BACKGROUND: The tumor microenvironment (TME) plays an important role in the progression of renal cell carcinoma (RCC). Cancer-associated fibroblasts (CAFs) are considered to constitute a major component of the TME and participate in various tumor-promoting molecular events. We have previously confir...
Autores principales: | Xu, Chao, Zhang, Keying, Yang, Fa, Zhou, Xiang, Liu, Shaojie, Li, Yu, Ma, Shanjin, Zhao, Xiaolong, Lu, Tong, Lu, Shiqi, Zhang, JiaYu, Li, Hongji, Han, Donghui, Wen, Weihong, Qin, Weijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712640/ https://www.ncbi.nlm.nih.gov/pubmed/34970489 http://dx.doi.org/10.3389/fonc.2021.773063 |
Ejemplares similares
-
CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma
por: Liu, Shaojie, et al.
Publicado: (2021) -
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021) -
The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021) -
CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation
por: Lu, Shiqi, et al.
Publicado: (2023) -
Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts
por: Liu, Shaojie, et al.
Publicado: (2022)